5.4 BPD, Apnea & Chronic Neonatal Lung Disease

5.4 BPD, Apnea & Chronic Neonatal Lung Disease

Bronchopulmonary Dysplasia, Apnea & Chronic Lung Disease

Bronchopulmonary dysplasia is a chronic respiratory-support phenotype in infants born very preterm. Modern disease reflects arrested alveolar and pulmonary vascular development superimposed on oxygen exposure, ventilation, infection, inflammation, and growth failure. The result is fewer, larger alveoli; reduced gas-exchange surface; abnormal vascular growth; heterogeneous resistance; and vulnerability to pulmonary hypertension.

Evidence-based severity at 36 weeks PMA

For infants born before 32 weeks, the Jensen evidence-based definition classifies BPD by respiratory support at 36 weeks postmenstrual age, regardless of the oxygen concentration:

An infant on 3 L/min HFNC is Grade 2 under this definition, even if FiO2 is 0.30 or higher. Do not blend older oxygen-based NIH categories with the Jensen grades. Always identify which definition a question supplies.

Clinical phenotype and evaluation

Infants may have tachypnea, retractions, wheeze, prolonged exhalation, carbon-dioxide retention, feeding fatigue, poor growth, and episodic desaturation. Evaluate airway obstruction, atelectasis, infection, aspiration, anemia, fluid status, and pulmonary hypertension rather than attributing every deterioration to BPD. Echocardiography screens for pulmonary hypertension and ventricular function; gas trends and growth trajectory help determine adequacy of support.

Respiratory and multidisciplinary management

• Use the lowest effective oxygen concentration while meeting the individualized saturation range, especially when pulmonary hypertension is present.
• In established severe BPD, a slower ventilator rate, longer inspiratory time, adequate expiratory time, and sufficient tidal volume may be needed for heterogeneous lungs; follow pressure, volume, and gas-exchange trends rather than one universal setting.
• Treat bronchospasm only when a bronchodilator response is demonstrated. Diuretics may help selected infants with pulmonary edema but require electrolyte and renal monitoring.
• Optimize nutrition, growth, immunization, aspiration evaluation, development, and caregiver education.
• Before discharge, verify oxygen and ventilator equipment, emergency tracheostomy or airway supplies when applicable, caregiver competency, follow-up, and a written escalation plan.

Apnea of prematurity results from immature respiratory control and is diagnosed after excluding infection, seizures, temperature disturbance, anemia, metabolic disease, and airway obstruction. Caffeine reduces apnea and supports extubation in appropriate preterm infants. A new apnea pattern in a previously stable infant is a clinical change that requires evaluation, not an automatic caffeine dose increase.

---

NPS Exam Traps

Exam Trap 1: Aggressive Normalization of PaCO2 in BPD

In an infant with established Grade 2 or 3 BPD, arterial blood gas often demonstrates a $\text{PaCO}_2$ of $55\text{ to }65\text{ mmHg}$ with a normal or slightly low $\text{pH}$ ($7.32\text{ to }7.36$) and a compensatory elevated bicarbonate ($28\text{ to }32\text{ mEq/L}$). Do not increase ventilator rate or tidal volume to force the $\text{PaCO}_2$ down to 40 mmHg. Aggressive hyperventilation causes volutrauma, barotrauma, and metabolic alkalosis, halting alveolar growth.

Exam Trap 2: Chronic Furosemide Complications

When an infant with BPD receives chronic daily furosemide without potassium supplementation, watch for two classic board exam traps: hypokalemic hypochloremic metabolic alkalosis on blood gas analysis, and nephrocalcinosis (renal medullary calcifications) or bone fractures on abdominal/chest imaging.

Deterioration and Discharge Cross-Check

A new oxygen requirement, rising carbon dioxide, feeding intolerance, or increased work of breathing in an infant with BPD is not automatically “baseline chronic lung disease.” Reassess tube or cannula position, secretion burden, atelectasis, infection, aspiration, anemia, fluid overload, airway malacia, pulmonary hypertension, and cardiac function. Compare with the infant’s established trend and response to bronchodilator or diuretic therapy rather than escalating every medication empirically.

Apnea in a preterm infant is a diagnosis of exclusion when the pattern is new or worsening. Check temperature, glucose, infection, anemia, reflux or aspiration, seizures, medication exposure, and airway obstruction. Document whether events include central pause, obstructive effort, bradycardia, desaturation, stimulation, or ventilation. Caffeine supports selected infants with apnea of prematurity, but dose changes follow weight, timing, serum concentration when indicated, and the neonatal plan.

Discharge planning tests the entire respiratory system around the child. Caregivers should demonstrate oxygen or ventilator setup, alarm response, suction, medication delivery, emergency bagging, and when to call emergency services. Confirm backup power and gas, travel calculations, equipment vendor support, smoke-free housing, safe sleep, feeding and aspiration plan, follow-up, immunoprophylaxis eligibility, and a written escalation pathway. An observed rooming-in period or structured competency checklist may reveal gaps before the infant leaves monitored care.